Ligand validation:8X22

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8X22_GOL_D_502	50%	90%	0.178	0.928	0.22	0.38	-	-	1	0	100%	1
8X22_GOL_C_603	45%	50%	0.207	0.939	1.09	0.85	-	-	0	0	100%	1
8X22_GOL_B_501	41%	48%	0.238	0.956	1.24	0.77	-	-	0	0	100%	1
8X22_GOL_D_501	39%	40%	0.202	0.909	1.15	1.19	-	1	0	0	100%	1
8X22_GOL_A_603	19%	50%	0.314	0.909	0.84	1.09	-	1	0	0	100%	1
8X22_GOL_A_604	9%	56%	0.272	0.763	0.93	0.77	-	-	3	0	100%	1
8X21_GOL_D_502	52%	31%	0.192	0.952	1.45	1.32	1	1	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.